The American Society of Health-System Pharmacists is leading a national search for an executive director to helm the End Drug Shortages Alliance. 

A phase 3 study of Amylyx Pharmaceuticals' approved therapy for amyotrophic lateral sclerosis, Relyvrio, failed to find significant efficacy results. By mid-June, the drugmaker might withdraw the drug. 

Pfizer's shortage of penicillin G benzathine injection, an antibiotic for syphilis and other bacterial infections, is now predicted to last until the end of 2024. 

Compared to 2018, the average diabetes patient now spends 129% more for their medications — largely affecting patients taking GLP-1s like Ozempic and Mounjaro, according to GoodRx. 

National clinical guidelines don't mention screening cancer patients for DPYD gene variants, but hospital pharmacy leaders are forging ahead with the patient safety practice, the American Society of Health-System Pharmacists reported March 6. 

Wegovy, Novo Nordisk's weight loss therapy part of a popular drug class, is now approved for reducing the risk of cardiovascular death, heart attack and stroke in adults who have cardiovascular disease and are either obese or overweight, the FDA…

It's past time to support pharmacists during times of crisis and patient care failures, which can cause second victim syndrome, according to American Pharmacists Association CEO Michael Hogue, PharmD. 

The FDA has informed Eli Lilly that it plans to convene a panel of independent experts to learn more about the safety and efficacy of donanemab, the company's proposed Alzheimer's drug. The move delays an FDA decision on the drug…

Two years after launching a company with a few dozen discounted generics, Mark Cuban's Cost Plus Drugs now offers more than 2,000 medications, partners with hundreds of independent and grocery chain pharmacies, and manufactures its own drugs. 

Nirsevimab, a new monoclonal antibody treatment for respiratory syncytial virus, was 90% effective at preventing hospitalizations among infants this virus season, according to a March 7 CDC report.